Fig 1.
Schematic describing the TABLE trial protocol for EQ-5D data collection.
Table 1.
Clinical and demographic characteristics at baseline.
Table 2.
Number of observations at each time point.
Table 3.
The number of observations (% share) across the three levels for each EQ-5D domain.
Fig 2.
Mean utility for TABLE trial patients with an ulcer versus a healed ulcer, split by treatment group, with 95% confidence intervals.
Table 4.
GEE GLM results with disutility as dependent variable, obs = 593.